Rekombinanter HLA-A2 Antikörper
-
- Target
- HLA-A2
- Antikörpertyp
- Recombinant Antibody
- Reaktivität
- Human
-
Wirt
- Maus
- Expressionssystem
- Mammalian cells
-
Klonalität
- Monoklonal
-
Konjugat
- Unkonjugiert
-
Applikation
- ELISA
- Verwendungszweck
- Recombinant Anti-HLA-A2-peptide (LLLTVLTVV) Complex (M3A1)
- Aufreinigung
- Protein A or G purified from cell culture supernatant.
- Reinheit
- >95 %
- Klon
- M3A1
- Isotyp
- IgG1
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- 0.01M PBS, pH 7.4.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at +4°C short term (1-2 weeks). Store at -20 °C 12 months. Store at -80°C long term.
-
- Target
- HLA-A2
- Hintergrund
- HLAA,Human leukocyte antigen A,HLA class I histocompatibility antigen,A alpha chain,HLA-A,PEMT,CA 15-3,H23AG,Peanut-reactive urinary mucin,PEM,EMA,Cancer antigen 15-3,MUC-1,Episialin,MUC1-CT,MUC1-beta,Tumor-associated mucin,CD227,Polymorphic epithelial mucin,KL-6,MUC1-alpha,MUC1,PUM,Krebs von den Lungen-6,MUC1-NT,Tumor-associated epithelial membrane antigen,Mucin-1,Breast carcinoma-associated antigen DF3,Carcinoma-associated mucin
-